secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2023-10-11T23:59:59+00:00
Accession:  0001654954-23-012783
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech announces 1-for-7 reverse share split effective October 11, 2023
------------------------------------------------------------------------------

- Reverse split reduces outstanding shares from ~21.5M to ~3.07M; no change in proportional ownership.
- No fractional shares issued; fractions rounding per British Columbia law.
- Adjustments made to equity awards and warrants exercise prices and shares.
- Shareholder approval not required under British Columbia corporate law.
- Common shares continue trading under symbol EDSA with new CUSIP 27966L306.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423012783/0001654954-23-012783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423012783/edsa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-012783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer